Literature DB >> 7284679

Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs.

S J Coker, I M Ledingham, J R Parratt, I J Zeitlin.   

Abstract

Acute coronary artery occlusion in anaesthetized open-chest greyhounds led to early release of thromboxane B2 (TxB2) into venous blood draining the ischaemic region. No release occurred from the remainder of the left ventricular wall (coronary sinus sampling). TxB2 release and ventricular ectopic activity were positively correlated (r = 0.863) 2 min post-occlusion. Aspirin (3 mg/kg i.v.) suppressed both local TxB2 release and ectopic activity and prevented ventricular fibrillation. It is suggested that TxB2 release is a factor contributing to early post-infarction arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7284679      PMCID: PMC2071639          DOI: 10.1111/j.1476-5381.1981.tb09138.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  3 in total

1.  Platelet aggregation in partially obstructed vessels and its elimination with aspirin.

Authors:  J D Folts; E B Crowell; G G Rowe
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

2.  Prophylactic lignocaine and early post-coronary artery occlusion dysrhythmias in anaesthetized greyhounds.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

3.  Antiarrhythmic effects of aspirin during nonthrombotic coronary occlusion.

Authors:  C B Moschos; B Haider; C De La Cruz; M M Lyons; T J Regan
Journal:  Circulation       Date:  1978-04       Impact factor: 29.690

  3 in total
  15 in total

1.  The effects of using a leukocyte removal filter during cold blood cardioplegia.

Authors:  T Ichihara; K Yasuura; T Maseki; A Matsuura; K Miyahara; T Ito; S Kato; S Mizuno; S Tamaki; A Seki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

2.  The effects of the combined administration of beta-adrenoceptor antagonists and non-steroidal anti-inflammatory drugs on ligation-induced arrhythmias in rats.

Authors:  O Fagbemi
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

3.  Therapeutic lidocaine concentrations have no effect on blood platelet function and plasma catecholamine levels.

Authors:  R F Berntsen; T Simonsen; G Sager; H Olsen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Lack of direct antiarrhythmic electrophysiological effects of salicylate on isolated guinea-pig myocardium.

Authors:  H Brasch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-08       Impact factor: 3.000

5.  Release of 6-keto-PGF1 alpha and thromboxane B2 in late appearing cardioprotection induced by the stable PGI analogue: 7-OXO-PGI.

Authors:  L Szekeres; A Tósaki
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

6.  Effects of dazoxiben on arrhythmias and ventricular fibrillation induced by coronary artery occlusion and reperfusion in anaesthetised greyhounds.

Authors:  S J Coker; J R Parratt
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

7.  The possible mechanism of protection induced by dexamethasone against sudden death due to coronary ligation in conscious rats.

Authors:  M Koltai; I Leprán; G Nemecz; L Szekeres
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

8.  AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion-induced arrhythmias in anaesthetized greyhounds.

Authors:  S J Coker; J R Parratt
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

Review 9.  Pathophysiology of myocardial ischemia: importance of platelet-vessel wall interactions.

Authors:  J R Parratt
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

10.  NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs.

Authors:  Cherry L Wainwright; Ashley M Miller; Lorraine M Work; Piero Del Soldato
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.